<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>ICH - Irubas Pharma Regulatory Portal</title>
  <style>
    body {
      margin: 0;
      font-family: Arial, sans-serif;
      background: #f8f9fa;
    }

    /* Header (same as FDA layout) */
    header {
      background-color: #d4e7f7;
      display: flex;
      align-items: center;
      padding: 10px 30px;
      border-bottom: 2px solid #b0cbea;
    }

    header img {
      height: 50px;
      margin-right: 15px;
    }

    header h1 {
      font-size: 26px;
      color: #003366;
      margin: 0;
      font-weight: bold;
    }

    /* Second bar (ICH info) */
    .sub-header {
      background-color: #b0cbea;
      color: #003366;
      display: flex;
      align-items: center;
      justify-content: flex-start;
      padding: 10px 30px;
      font-weight: bold;
      border-bottom: 1px solid #9cbadd;
      font-size: 20px;
    }

    .sub-header img {
      height: 50px;
      margin-right: 15px;
    }

    .sub-header span {
      font-size: 18px;
      font-weight: bold;
    }

    .home-icon {
      height: 35px;
      width: 35px;
      margin-right: 20px;
      cursor: pointer;
    }

    /* Third line (hover-highlight nav like FDA) */
    nav {
      background-color: #d4e7f7;
      display: flex;
      justify-content: center;
      gap: 45px;
      padding: 14px 0;
      font-weight: bold;
      border-bottom: 2px solid #aac3de;
    }

    nav a {
      text-decoration: none;
      color: #003366;
      font-size: 16px;
      position: relative;
      transition: all 0.3s ease;
    }

    nav a:hover {
      color: #001f4d;
    }

    nav a::after {
      content: "";
      position: absolute;
      bottom: -6px;
      left: 0;
      width: 0%;
      height: 2px;
      background-color: #003366;
      transition: width 0.3s ease;
    }

    nav a:hover::after {
      width: 100%;
    }

    /* Content section */
    .content {
      max-width: 1000px;
      margin: 40px auto;
      background-color: #ffffff;
      padding: 30px;
      border-radius: 10px;
      box-shadow: 0 2px 6px rgba(0,0,0,0.1);
      line-height: 1.8;
      color: #333;
    }

    h2 {
      color: #003366;
      border-bottom: 2px solid #aac3de;
      padding-bottom: 5px;
    }

    .faq {
      margin-top: 40px;
    }

    details {
      margin: 10px 0;
      background-color: #f4f7fb;
      padding: 10px;
      border-left: 4px solid #0055aa;
      border-radius: 4px;
    }

    summary {
      font-weight: bold;
      cursor: pointer;
      color: #003366;
    }

    p {
      margin: 10px 0 0 10px;
    }
  </style>
</head>
<body>

  <!-- First line -->
  <header>
    <img src="irubas-logo.png" alt="Irubas Logo">
    <h1>IRUBAS</h1>
  </header>

  <!-- Second line -->
  <div class="sub-header">
    <a href="index.html"><img src="home.png" alt="Home" class="home-icon"></a>
    <img src="ich-logo.png" alt="ICH Logo">
    <div>
      ICH <span>(International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)</span>
    </div>
  </div>

  <!-- Third line -->
  <nav>
    <a href="https://www.ich.org/" target="_blank">ICH OFFICIAL SITE</a>
    <a href="https://www.ich.org/page/quality-guidelines" target="_blank">QUALITY GUIDELINES</a>
    <a href="https://www.ich.org/page/safety-guidelines" target="_blank">SAFETY GUIDELINES</a>
    <a href="https://www.ich.org/page/efficacy-guidelines" target="_blank">EFFICACY GUIDELINES</a>
    <a href="https://www.ich.org/page/multidisciplinary-guidelines" target="_blank">MULTIDISCIPLINARY</a>
<a href="https://www.ich.org/page/training-library" target="_blank">TRAINING</a>
 <a href="https://www.ich.org/page/history" target="_blank">ICH HISTORY</a>
  </nav>

  <!-- Content section -->
  <div class="content">
    <h2>About ICH</h2>
    <p>The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an initiative that brings together regulatory authorities and the pharmaceutical industry to discuss scientific and technical aspects of drug registration. It aims to harmonize guidelines and standards to ensure safe, effective, and high-quality medicines are developed and registered efficiently worldwide.</p>

    <p>Established in 1990, ICHâ€™s mission is to achieve greater harmonisation worldwide to ensure that safe, effective, and high-quality medicines are developed and registered efficiently, benefiting both industry and patients.</p>

    <h2>Main Responsibilities</h2>
    <ul>
      <li>Develop and maintain harmonised guidelines for quality, safety, efficacy, and multidisciplinary topics.</li>
      <li>Promote international cooperation among regulatory agencies and the pharmaceutical industry.</li>
      <li>Reduce duplication of clinical trials and data submissions by harmonising regulatory standards.</li>
      <li>Support the implementation of harmonised guidelines in regulatory systems worldwide.</li>
      <li>Facilitate continuous improvement of pharmaceutical regulations to meet scientific advancements.</li>
    </ul>

  <div class="faq">
      <h2>Frequently Asked Questions</h2>
      <details>
        <summary>What is the purpose of ICH?</summary>
        <p>ICH aims to harmonise the technical requirements for the registration of pharmaceuticals among major global markets, reducing duplication and ensuring patient safety.</p>
      </details>
      <details>
        <summary>Which regions are part of ICH?</summary>
        <p>ICH includes regulatory authorities and industry associations from Europe (EMA), Japan (MHLW/PMDA), the United States (FDA), and other regions worldwide.</p>
      </details>
       <details>
        <summary>What is the ICH Official Site?</summary>
        <p>The ICH official site is the central platform providing access to all harmonised guidelines, updates, press releases, and working documents. It supports global collaboration between regulatory authorities and industry to ensure uniform standards in pharmaceutical quality, safety, and efficacy across different regions.</p>
      </details>
<details>
        <summary>What are Quality Guidelines?</summary>
        <p>Quality Guidelines define global standards for pharmaceutical product development, manufacturing, and control. They address areas like stability testing, impurities, analytical validation, and good manufacturing practices. These guidelines ensure that all drug products consistently meet high-quality standards, enhancing patient safety and regulatory trust.</p>
      </details>
<details>
        <summary>What are Safety Guidelines?</summary>
        <p>Safety Guidelines describe non-clinical and clinical testing principles to evaluate potential toxicological, pharmacological, and biological risks of drug candidates. They focus on carcinogenicity, genotoxicity, reproductive toxicity, and immunotoxicity to ensure human safety before and during clinical trials.</p>
      </details>
<details>
        <summary>What are Efficacy Guidelines?</summary>
        <p>Efficacy Guidelines outline the scientific and regulatory standards for designing and conducting clinical trials. They guide how medicines should be tested for effectiveness, dosage, and therapeutic use to ensure consistent and reliable clinical data supporting regulatory approval.</p>
      </details>
<details>
        <summary>What are Multidisciplinary Guidelines?</summary>
        <p>Multidisciplinary Guidelines cover topics that span multiple ICH categories, such as the Common Technical Document (CTD), Medical Dictionary for Regulatory Activities (MedDRA), and electronic data submissions. They streamline communication and data sharing across global pharmaceutical regulatory systems.</p>
      </details>
<details>
        <summary>What is ICH Training?</summary>
        <p>ICH Training provides educational materials, webinars, and guidance to help regulatory professionals, industry experts, and students understand and apply ICH guidelines effectively. It promotes global harmonisation and consistent implementation of pharmaceutical standards.</p>
      </details>
<details>
        <summary>What is the History of ICH?</summary>
        <p>The ICH was founded in 1990 by regulatory bodies and industry associations from Europe, the USA, and Japan to harmonise technical drug requirements. Over time, it has expanded globally, reducing duplication, improving public health, and fostering regulatory cooperation.</p>
      </details>

<details>
        <summary>How does ICH benefit the pharmaceutical industry?</summary>
        <p>ICH helps streamline global regulatory processes, reducing costs, time, and duplication in pharmaceutical development and approval.</p>
      </details>
    </div>
  </div>


</body>
</html>

